乙型肝炎病毒相关急性慢性肝功能衰竭患者的长期预后：一

StephenW

Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study

Liver International — Lin S, et al. | March 12, 2019

Advertisement

A sum of 814 candidates were analyzed to estimate the 5-year survival rate and incidence rate of hepatocellular carcinoma (HCC) in subjects with hepatitis B virus-related acute on chronic liver failure (HBV-ACLF) vs cases with HBV-cirrhosis. Authors recorded 55.28% of cases with compensated cirrhosis and 29.73% of subjects with decompensated cirrhosis. They noted a higher 5-year survival rate of patients with ACLF (97.2%) as compared to subjects with decompensated cirrhosis (86.0%) but lesser than cases with compensated cirrhosis (99.1%). They concluded a better long-term prognosis among subjects with ACLF who survived the first 3 months as compared to decompensated cirrhosis whereas a similarity was noted between the HCC risk and the compensated cirrhosis.

StephenW

乙型肝炎病毒相关急性慢性肝功能衰竭患者的长期预后：一项观察性队列研究

肝脏国际 - 林思，等。| 2019年3月12日



对814名候选人进行了分析，以评估乙型肝炎病毒相关急性慢性肝衰竭（HBV-ACLF）患者与HBV肝硬化患者的5年生存率和肝细胞癌（HCC）发病率。 作者记录了55.28％的代偿性肝硬化病例和29.73％的失代偿期肝硬化病人。 他们指出，ACLF患者的5年生存率（97.2％）高于失代偿期肝硬化患者（86.0％），但低于代偿性肝硬化患者（99.1％）。 他们得出结论，与失代偿期肝硬化相比，前3个月存活的ACLF患者的长期预后更好，而HCC风险与代偿性肝硬化之间存在相似性。

StephenW

https://onlinelibrary.wiley.com/ ... hzKhqfqMBJVfA%3D%3D